Indee Labs announces a $2M contract with the National Cancer Institute to scale up and out the Hydropore™ platform for cell therapy with Eyquem Lab at UCSF. BERKELEY, Calif., Nov. 2, 2022 ...

BERKELEY, Calif. and PACIFICA, Calif., Dec. 1, 2022 /PRNewswire/ -- Indee Labs is a biotechnology company developing the Hydropore ™ for non-viral intracellular delivery. Monomer Bio enables ...

Indee Labs partners with Monomer Bio to automate Hydropore™ workflows for engineered T cells and similar immune cell types. BERKELEY, Calif. and PACIFICA, Calif., Dec. 1, 2022 /PRNewswire ...

As part of the partnership, Monomer Bio will provide Indee Labs with the software and automation expertise required to implement their pre- and post- Hydropore ™ processing workflows using off ...

Indee Labs partners with Monomer Bio to automate Hydropore™ workflows for engineered T cells and similar immune cell types. BERKELEY, Calif. and PACIFICA, Calif., Dec. 1, 2022 /PRNewswire ...

Indee Labs' research collaboration with GenScript aims to develop a DNA knock-in kit for Hydropore™ to enable large transgene inserts above the 5 kb limit for AAV BERKELEY, Calif., Feb. 16, 2023 ...

Indee Labs announces an exclusive marketing and distribution deal with Sunko Instruments in China for Hydropore Research Use Only. BERKELEY, Calif., May 25, 2023 /PRNewswire/ -- Indee Labs is a ...

Indee Labs' research collaboration with GenScript aims to develop a DNA knock-in kit for Hydropore™ to enable large transgene inserts above the 5 kb limit for AAV BERKELEY, Calif., Feb. 16, 2023 ...

Indee Labs to complete the development and launch of Hydropore RUO and Cell Therapy along with a direct DNA knock-in kit, enabled by BroadOak's strategic investment and domain expertise. BERKELEY ...